EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

BEAC Induction Regimen and Prior Thoracic Radiotherapy Increases the Risk of ASCT-Associated Pneumonitis

Elina Kaprio, Anna Jokimäki, Hanne Kuitunen, Joel Kontiainen, Tuomas Selander, Taina Turpeenniemi-Hujanen, Outi Kuittinen

Acta Haematologica · 09.03.2026 · 1-9

DOI: 10.1159/000551311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica, online erschienen am 09.03.2026. Verfasst von Elina Kaprio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland, elina.kaprio@fimnet.fi. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

High-dose chemotherapy (HDT) followed by autologous stem cell transplant (ASCT) has been standard of care in the treatment of relapsed and refractory lymphoma. Some severe toxicities are associated with this treatment modality. Pulmonary toxicity is one of these significant adverse effects and a potential cause of treatment-related mortality.

Methods

In this retrospective study, we report the incidence, risk factors, and outcome of treatment-induced pneumonitis in 286 lymphoma patients receiving HDT followed by ASCT.

Results

The cumulative incidence of treatment-induced pneumonitis was 4.6% and occurred in 11/286 patients. Three months incidence rate was 2.6%. Most of the patients diagnosed with treatment-induced pneumonitis had received BEAC as HDT regimen. The risk of treatment-induced pneumonitis was higher if HDT-ASCT was given in later treatment lines. Also, a prior thoracic radiotherapy as part of first-line treatment was associated with higher risk for pneumonitis after HDT-ASCT. In 2 patients, the pneumonitis did not respond to high-dose steroid treatment.

Conclusion

This study provides new information about the incidence of pneumonitis associated with HDT-ASCT and its risk factors, which might be useful to take into consideration during and after treatment with HDT-ASCT.

Schlagwörter

Stichwörter der Autor:innen

Autologous stem cell transplantHigh-dose chemotherapyLymphomaTreatment-induced pneumonitis

Autor:innen und Institutionen

  • Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland, elina.kaprio@fimnet.fi.
  • Central Hospital of Southern Osthrobotnia, Seinäjoki, Finland, elina.kaprio@fimnet.fi.
  • Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.
  • Oulu University Hospital, Medical Research Center and Cancer Centre, Oulu University Hospital, Oulu, Finland.
  • Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Science Service Center, Kuopio University Hospital, Kuopio, Finland.

Zitieren

APA

Kaprio, E., Jokimäki, A., Kuitunen, H., Kontiainen, J., Selander, T., Turpeenniemi-Hujanen, T., & Kuittinen, O. (2026). BEAC Induction Regimen and Prior Thoracic Radiotherapy Increases the Risk of ASCT-Associated Pneumonitis. Acta Haematologica, 1-9. https://doi.org/10.1159/000551311

Vancouver

Kaprio E, Jokimäki A, Kuitunen H, Kontiainen J, Selander T, Turpeenniemi-Hujanen T, et al. BEAC Induction Regimen and Prior Thoracic Radiotherapy Increases the Risk of ASCT-Associated Pneumonitis. Acta Haematologica. 2026:1-9. doi:10.1159/000551311

BibTeX
@article{Kaprio2026,
  author = {Kaprio, Elina and Jokimäki, Anna and Kuitunen, Hanne and Kontiainen, Joel and Selander, Tuomas and Turpeenniemi-Hujanen, Taina and Kuittinen, Outi},
  title = {BEAC Induction Regimen and Prior Thoracic Radiotherapy Increases the Risk of ASCT-Associated Pneumonitis},
  journal = {Acta Haematologica},
  year = {2026},
  pages = {1--9},
  doi = {10.1159/000551311}
}
Kostenlos starten →